Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti‐TNF agent: a multicentre cohort study

PaperCitations, authors & open-access status

Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti‐TNF agent: a multicentre cohort study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 47 citations, 2020 year and closed oa status.

47
Citations
2020
Year
closed
OA Status

Related on ScholarIQ

Ludovic Caillo
Author
Alimentary Pharmacology & Therapeutics
Journal
Inflammatory Bowel Disease
Topic
Inflammatory Bowel Disease
Topic
Rheumatoid Arthritis Research and Therapies
Topic
Liver Diseases and Immunity
Topic
470M+ articles · free account